Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zee
    NGS specialist
    • Apr 2008
    • 249

    #1

    Experiences with the new Human GRC38

    Happy New year 2014 All,

    We have been running some tests with the new GRC38 and our aligner, Novoalign. It seems there are some alternate sequences that are in there which Im assuming are for completeness sake.

    Are there any recommendations for how we should be aligning to this new build i.e. do we stick with the methods used in GATK best practices where we align to the complete chromosome sequences?

    Based on some of our own testing we see that These alternate assembly sequences have 111Kbp and cover 3.6% of human genome. The big question... Should these be used in the search space?

    So we aligned some Exome reads against full GRC38 and GRC38 without the alternate assemble sequences.

    Without Alt sequences..
    # Pairs Aligned: 11,939,446
    # Unique Alignment: 22,945,232

    with Alt sequences
    # Pairs Aligned: 11,942,662
    # Unique Alignment: 22,278,528

    So including the Alt sequences aligned 0.03% extra pairs however there were 3% extra multi-mapped reads which is pretty high considering the alternate sequences are 3.6% of the genome. These multi-mappers are going to result in low quality alignments and seriously impact variant calling for these regions.

    So for now we feel that not including the alternate sequences may be a better approach. We would like to get a feel for what the general consensus is among the community. Are there any papers released by the Broad or some of the other centers that address this?

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
35 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...